Trial Outcomes & Findings for Neo-nervegenesis in Inguinal Hernia Implant ProFlor (NCT NCT04171102)

NCT ID: NCT04171102

Last Updated: 2020-06-17

Results Overview

Post-operative assessment of neonervegenesis within hernia implant ProFlor at short, mid and long term post-implantation

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

15 participants

Primary outcome timeframe

3 weeks until 8 months post-implantation

Results posted on

2020-06-17

Participant Flow

Participant milestones

Participant milestones
Measure
Neonervegenesis in ProFlor Hernia Implant in the Short Term
Determining presence and level of maturation of nervous structures in the hernia implant ProFlor at 3-5 weeks post-implantation
Neonervegenesis in ProFlor Hernia Implant in the Mid Term
Determining presence and level of maturation of nervous structures in the hernia implant ProFlor at 3-4 months post-implantation
Neonervegenesis in ProFlor Hernia Implant in the Long Term
Determining presence and level of maturation of nervous structures in the hernia implant ProFlor at 6-8 months post-implantation
Overall Study
STARTED
4
5
6
Overall Study
COMPLETED
4
5
6
Overall Study
NOT COMPLETED
0
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Race and Ethnicity were not collected from any participant.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Short Term Post-implantation
n=4 Participants
Determining presence and level of maturation of nervous structures in the hernia implant ProFlor at 3-5 weeks post-implantation
Mid Term Post-implantation
n=5 Participants
Determining presence and level of maturation of nervous structures in the hernia implant ProFlor at 3-4 months post-implantation
Long Term Post-implantation
n=6 Participants
Determining presence and level of maturation of nervous structures in the hernia implant ProFlor at 6-8 months post-implantation
Total
n=15 Participants
Total of all reporting groups
Age, Categorical
<=18 years
0 Participants
n=4 Participants
0 Participants
n=5 Participants
0 Participants
n=6 Participants
0 Participants
n=15 Participants
Age, Categorical
Between 18 and 65 years
3 Participants
n=4 Participants
3 Participants
n=5 Participants
5 Participants
n=6 Participants
11 Participants
n=15 Participants
Age, Categorical
>=65 years
1 Participants
n=4 Participants
2 Participants
n=5 Participants
1 Participants
n=6 Participants
4 Participants
n=15 Participants
Age, Continuous
53.6 years
STANDARD_DEVIATION 4561 • n=4 Participants
59.6 years
STANDARD_DEVIATION 4871 • n=5 Participants
61.5 years
STANDARD_DEVIATION 4881 • n=6 Participants
58.23 years
STANDARD_DEVIATION 4581 • n=15 Participants
Sex: Female, Male
Female
0 Participants
n=4 Participants
0 Participants
n=5 Participants
0 Participants
n=6 Participants
0 Participants
n=15 Participants
Sex: Female, Male
Male
4 Participants
n=4 Participants
5 Participants
n=5 Participants
6 Participants
n=6 Participants
15 Participants
n=15 Participants
Race and Ethnicity Not Collected
0 Participants
Race and Ethnicity were not collected from any participant.
Region of Enrollment
Italy
4 Participants
n=4 Participants
5 Participants
n=5 Participants
6 Participants
n=6 Participants
15 Participants
n=15 Participants

PRIMARY outcome

Timeframe: 3 weeks until 8 months post-implantation

Population: Patients who underwent inguinal hernia repair with ProFlor

Post-operative assessment of neonervegenesis within hernia implant ProFlor at short, mid and long term post-implantation

Outcome measures

Outcome measures
Measure
Short Term Post Implantation
n=4 Participants
Determining presence and level of maturation of nervous structures in the hernia implant ProFlor at 3-5 weeks post implantation
Mid Term Post Implantation
n=5 Participants
Determining presence and level of maturation of nervous structures in the hernia implant ProFlor at 3-4 months post implantation
Long Term Post-implantation
n=6 Participants
Determining presence and level of maturation of nervous structures in the hernia implant ProFlor at 6-8 months post implantation
Ingrowth of Newly Formed Nervous Elements Within Hernia Implant ProFlor
999.75 μm^2
Standard Deviation 113.32
1044 μm^2
Standard Deviation 695.95
2094 μm^2
Standard Deviation 490.82

Adverse Events

Short Term Post-implantation

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Mid Term Post-implantation

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Long Term Post-implantation

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Prof. Dr. Giuseppe Amato

University of Cagliari

Phone: 337963197

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place